UNSPSC 51151637: Elantrine

This classification denotes an anticholinergic agent with the molecular formula C20H24N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MV4FO7V23V, chemically known as rmi 80,029 but generally known as elantrine, which bears US NIH Compound Identifier 5383521. European Medicines Agency schedules Elantrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06476MIG. The term ELANTRINE is an International Non-Proprietary Name.

UNSPSC 51151637 Elantrine, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The single recent opportunity in the dataset—Seminole County, Florida's IFB for naloxone and safe drug deactivation systems—represents public health supply procurement, not elantrine (a chemical compound used in industrial or pharmaceutical synthesis). The mismatch suggests either a miscoding of the county's solicitation or a misalignment between the code's nominal scope and actual buying patterns in state and local procurement systems.

Seminole County's IFB60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually on a two-year initial term with one-year renewal option. Quarterly deliveries were required to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for all shipping and delivery costs. Bidders had to comply with drug-free workplace certification, E-Verify requirements, and carry workers' compensation, commercial general liability, and professional liability insurance. The source provides no evidence of additional recent opportunities under this code, geographic spread across other jurisdictions, or repeat issuing bodies. The code shows limited actionable recent activity for business development purposes.